Systematic Reviews of Treatments for Multiple Sclerosis

Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for multiple sclerosis.
Reviewed September 2008

Printer friendly page

19 Resources Found
Results 1 to 19 displayed.
Title:   Multidisciplinary rehabilitation for adults with multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis is a chronic neurological condition, which can cause multiple disabilities and limit participation in young adults. This review looked for evidence of MD rehabilitation in adults with multiple sclerosis. The authors concluded there wa...
Date:   Jun 2006
Title:   Interferon in relapsing-remitting multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults. Repeated damage to the myelin sheaths and other parts of the nerves can lead to serious disability. MS may be related to the immune system. In...
Date:   Jul 2001
Title:   Intravenous immunoglobulins for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults. MS disrupts the ability of nerves to conduct electrical impulses, and can lead to permanent disability. MS might be related to the immune syst...
Date:   Apr 2003
Title:   Corticosteroids or ACTH for acute exacerbations in multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults. A disruption in the ability of the nerves to conduct electrical impulses to and from the brain produces the many symptoms of MS which can lead...
Date:   Jul 2000
Title:   Mitoxantrone for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Mitoxantrone (MX) is an immunosuppressive drug, which is commonly used in patients affected by relapsing-remitting (RR), progressive relapsing (PR) and secondary progressive course (SP) multiple sclerosis (MS). MS is an immune-mediated chronic disorder ...
Date:   Aug 2005
Title:   Occupational therapy for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults. MS causes disruption of the ability of nerves to conduct electrical impulses, leading to symptoms such as muscle weakness, fatigue and loss of...
Date:   May 2003
Title:   Hyperbaric oxygen therapy for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults. Repeated damage to parts of the nerves leads to progressive weakness and disability. Hyperbaric oxygen therapy (HBOT) involves people breathin...
Date:   Apr 2004
Title:   Aminopyridines for symptomatic treatment in multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis (MS) is a disease that affects young and middle-aged adults, causing different symptoms in individuals. It is caused by damage to the myelin sheaths (fibres that wrap around and protect the nerves and spinal cord). Potassium (a minera...
Date:   Jul 2002
Title:   Amantadine for fatigue in multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis (MS) is a chronic disease affecting young and middle-aged adults. One of the most common and disabling symptoms of MS is fatigue. Different approaches have been used to try and improve this, including energy conservation, specialised ...
Date:   Nov 2006
Title:   Anti-spasticity agents for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults. Spasticity, a common problem in people with MS, is a disorder of voluntary movement caused by damage to the central nervous system. The main s...
Date:   Jul 2003
Title:   Corticosteroids for the long-term treatment in multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis is an inflammatory disease affecting the brain and spinal cord. It results in episodes of neurological deficit which recover (relapses) as well as accumulation of sustained disability with the passage of time. Corticosteroids are pote...
Date:   Sep 2007
Title:   Methotrexate for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Further trials of methotrexate for MS are neededMultiple sclerosis (MS) is an immune disease of the nervous system. Drugs that interfer with the immune system, such as methotrexate could benefit people with the disease. To date research suggest that the...
Date:   Oct 2007
Title:   Therapy with glatiramer acetate for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middle-aged adults and can lead to permanent disability. MS damages several parts of the nerves, including the myelin sheath. Glatiramer acetate (Copaxone ?) is a...
Date:   Jun 2003
Title:   Exercise therapy for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   MS is a chronic disease of the central nervous system. The variable distribution of the damage in the myelin sheath of nerves may lead to loss of strength, sensation, co-ordination and balance causing severe and progressive limitations of function in da...
Date:   Feb 2004
Title:   Azathioprine for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   AZA is a possible alternative to interferon beta for treating MS. As concerns have been raised about its safety, mainly due to possible increased risk of cancer, the authors of this review tried to assess the balance between benefits and harms of AZA tr...
Date:   May 2007
Title:   Treatment for ataxia in multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   MS is a chronic disease of the central nervous system which typically affects both young and middle aged adults. It can result in many different symptoms including ataxia....
Date:   Aug 2006
Title:   Dietary interventions for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Because available conventional treatments are only partially effective and may produce side effects, most patients with MS use therapies proposed by complementary and alternative medicine - usually diets and dietary supplements. In fact, an Internet sea...
Date:   Oct 2006
Title:   Cyclophosphamide for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   MS is a chronic disease of the nervous system affecting young and middle-aged adults. MS is supposed to be related to the immune system. CFX is an immunosuppressive drug used for various autoimmune diseases. As its use for MS is controversial, the Auth...
Date:   Nov 2006
Title:   Psychological interventions for multiple sclerosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   In many countries MS is the most common neurological disorder among young adults. Its impact can be overwhelming with the person facing the likelihood of reduced physical function and of disability, with consequent disruptions in education, employment, ...
Date:   Nov 2005
Results 1 to 19 displayed.